Abstract
Supervoltage radiotherapy, in this instance with a 22 MeV betatron, permits the systematic use of high-dose whole-pelvis irradiation in the treatment of bulky primary lesions, late stages of cancer of the uterine cervix and in the biologically more aggressive tumors associated with pregnancy.